Template:Myeloid malignancy: Difference between revisions

From WikiMD's Wellness Encyclopedia

en>Andrybak
categorization (via WP:JWB)
 
m 1 revision imported
 
(One intermediate revision by the same user not shown)
Line 2: Line 2:
  | name = Myeloid malignancy
  | name = Myeloid malignancy
  | state = {{{state<includeonly>|autocollapse</includeonly>}}}
  | state = {{{state<includeonly>|autocollapse</includeonly>}}}
  | title = [[Myeloid]]-related [[h{{Yesno|{{{us|}}}|yes=|no=a|blank=a}}ematological malignancy]]
  | title = [[Myeloid]]-related [[hematological malignancy]]


  | listclass = hlist
  | listclass = hlist


Line 15: Line 16:
     | list1 = {{Navbox|child
     | list1 = {{Navbox|child


       | group1 = {{nobold|''[[Acute myeloid leukemia|AML]]''}}
       | group1 = {{nobold|''[[Acute myeloid leukemia|AML]]:''}}
       | list1 =
       | list1 =
* [[Acute myeloblastic leukemia]]
* [[Acute myeloblastic leukemia]]
Line 98: Line 99:
     | group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}}
     | group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}}
     | list2 =
     | list2 =
* [[Essential thrombocyth{{Yesno|{{{us|}}}|yes=|no=a|blank=a}}emia]]
* [[Essential thrombocytosis]]


* [[Acute megakaryoblastic leukemia]]
* [[Acute megakaryoblastic leukemia]]


   }}
   }}
Line 113: Line 115:
     | group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}}
     | group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}}
     | list2 =
     | list2 =
* [[Polycyth{{Yesno|{{{us|}}}|yes=|no=a|blank=a}}emia vera]]
* [[Polycythemia vera]]


     | group3 = {{nobold|''[[Myelodysplastic syndrome|MD]]''}}
     | group3 = {{nobold|''[[Myelodysplastic syndrome|MD]]''}}
Line 121: Line 123:
* [[Chromosome 5q deletion syndrome]]
* [[Chromosome 5q deletion syndrome]]
* [[Sideroblastic anemia]]
* [[Sideroblastic anemia]]
* [[Paroxysmal nocturnal h{{Yesno|{{{us|}}}|yes=|no=a|blank=a}}emoglobinuria]]
* [[Paroxysmal nocturnal hemoglobinuria]]
* [[Refractory cytopenia with multilineage dysplasia]]
* [[Refractory cytopenia with multilineage dysplasia]]


Line 136: Line 138:
* [[Mastocytosis|Systemic mastocytosis]]
* [[Mastocytosis|Systemic mastocytosis]]


   | group2 = {{nobold|[[Mastocytosis]]}}
   | group2 = {{nobold|[[Mastocytosis]]:}}
   | list2 =
   | list2 =
* [[Diffuse cutaneous mastocytosis]]
* [[Diffuse cutaneous mastocytosis]]
Line 161: Line 163:
   | group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}}
   | group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}}
   | list2 =
   | list2 =
* [[Primary myelofibrosis]]
* [[Myelofibrosis]]
* [[Biphenotypic acute leukaemia]]
* [[Acute biphenotypic leukaemia]]


  }}
  }}


}}<noinclude>
}}<noinclude>
{{Documentation|content=
{{collapsible option}}
{{Collapsible option}}
[[Category:Oncology templates]]
[[Category:Oncology navigational boxes]]
[[Category:Immunology templates]]
[[Category:Immunology navigational boxes]]
</noinclude>
}}</noinclude>
{{no-index-template}}

Latest revision as of 19:46, 8 March 2025